BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 2359501)

  • 1. [Cytological exam of the pleural fluid in the diagnosis of neoplastic pleuritis. Cases contribution].
    Vignale L; Galli G; Rossi PC; Parentini GC
    Minerva Med; 1990 Jun; 81(6):455-9. PubMed ID: 2359501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effusion cytology in the diagnosis of malignant epithelioid and biphasic pleural mesothelioma.
    Sherman ME; Mark EJ
    Arch Pathol Lab Med; 1990 Aug; 114(8):845-51. PubMed ID: 2375659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positive effusion cytology as the initial presentation of malignancy.
    Monte SA; Ehya H; Lang WR
    Acta Cytol; 1987; 31(4):448-52. PubMed ID: 3604540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cytodiagnosis of pleural mesotheliomas].
    Castelain G; Castelain C; Pretet S; Kreis B
    Presse Med (1893); 1969 Feb; 77(6):197-9. PubMed ID: 4182143
    [No Abstract]   [Full Text] [Related]  

  • 5. The distinction of mesothelioma from adenocarcinoma in malignant effusions by electron microscopy.
    Kobzik L; Antman KH; Warhol MJ
    Acta Cytol; 1985; 29(3):219-25. PubMed ID: 3859121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The value of ThinPrep and cytospin preparation in pleural effusion cytological diagnosis of mesothelioma and adenocarcinoma.
    Ylagan LR; Zhai J
    Diagn Cytopathol; 2005 Mar; 32(3):137-44. PubMed ID: 15690333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The interval between the diagnosis of malignancy and the development of effusions, with reference to the role of cytologic diagnosis.
    van de Molengraft FJ; Vooijs GP
    Acta Cytol; 1988; 32(2):183-7. PubMed ID: 3348059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnostic value of the combined determination of carcinoembryonic antigen (CEA) in pleural effusion and serum with an enzyme immunoassay (EIA). Sensitivity, specificity and relation to tumor type].
    Klech H; Rona G; Hutter C; Bayer PM; Kummer F
    Wien Klin Wochenschr; 1986 Sep; 98(17):564-73. PubMed ID: 3020811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adaptation of a commercial fluorescent in situ hybridization test to the diagnosis of malignant cells in effusions.
    Flores-Staino C; Darai-Ramqvist E; Dobra K; Hjerpe A
    Lung Cancer; 2010 Apr; 68(1):39-43. PubMed ID: 19523712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive models for diagnosis of pleural effusions secondary to tuberculosis or cancer.
    Sales RK; Vargas FS; Capelozzi VL; Seiscento M; Genofre EH; Teixeira LR; Antonangelo L
    Respirology; 2009 Nov; 14(8):1128-33. PubMed ID: 19909461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local immunotherapy with interferon-alpha in metastatic pleural and peritoneal effusions: correlation with immunologic parameters.
    Stathopoulos GP; Baxevanis CN; Papadopoulos NG; Zarkadis IK; Papacostas P; Michailakis E; Tsiatas ML; Papamichail M
    Anticancer Res; 1996; 16(6B):3855-60. PubMed ID: 9042270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cytologic diagnosis of malignant neoplasms in pleural and peritoneal effusions.
    Sears D; Hajdu SI
    Acta Cytol; 1987; 31(2):85-97. PubMed ID: 3469856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The diagnostic yield of pleural fluid cytology in malignant pleural effusions.
    Ong KC; Indumathi V; Poh WT; Ong YY
    Singapore Med J; 2000 Jan; 41(1):19-23. PubMed ID: 10783675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytogenetic analysis of effusions from malignant mesothelioma. A diagnostic adjunct to cytology.
    Granados R; Cibas ES; Fletcher JA
    Acta Cytol; 1994; 38(5):711-7. PubMed ID: 8091903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical and cytological features of diffuse mesotheliomas of the pleura.
    Matzel W
    Arch Geschwulstforsch; 1985; 55(4):259-64. PubMed ID: 4037997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the nerve growth factor receptors TrkA and p75 in malignant mesothelioma.
    Davidson B; Reich R; Lazarovici P; Flørenes VA; Risberg B; Nielsen S; Sert B; Bedrossian C
    Lung Cancer; 2004 May; 44(2):159-65. PubMed ID: 15084380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Significance of combining detection of E-cadherin, carcinoembryonic antigen, and calretinin in cytological differential diagnosis of serous effusion].
    Su XY; Li GD; Liu HB; Jiang LL
    Ai Zheng; 2004 Oct; 23(10):1185-9. PubMed ID: 15473932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The sensitivity of cytologic evaluation of pleural fluid in the diagnosis of malignant mesothelioma.
    Rakha EA; Patil S; Abdulla K; Abdulkader M; Chaudry Z; Soomro IN
    Diagn Cytopathol; 2010 Dec; 38(12):874-9. PubMed ID: 20049969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of types and primary sites of malignant tumors by examination of exfoliated tumor cells in serous fluids. Comparison with the diagnostic accuracy on small histologic biopsies.
    Spieler P; Gloor F
    Acta Cytol; 1985; 29(5):753-67. PubMed ID: 2996273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant pleural effusions.
    Sahn SA
    Clin Chest Med; 1985 Mar; 6(1):113-25. PubMed ID: 2988851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.